Home » Topics » Regulatory

Regulatory
RSS

Canadian authorities approve use of Fragmin in treatment of heart disease

Aug. 31, 1998

Hoechst Marion Roussel and 3M file NDA for QVAR

Aug. 28, 1998

CIBIS-II study results confirm benefits of beta-blockade in heart failure

Aug. 27, 1998

FDA approves first treatment for Crohn's disease

Aug. 27, 1998

MOXCON study will test the efficacy of SIRAs in treating heart failure

Aug. 27, 1998

SSRI produces significant improvements in patients with social phobia

Aug. 26, 1998

First approval for lamivudine in chronic hepatitis B

Aug. 25, 1998

New indication approved for AmBisome in the U.K.

Aug. 24, 1998

Thymosin alpha 1 receives patent protection for hepatitis C indication

Aug. 24, 1998

Canadian launch announced for Zyban sustained-release tablets

Aug. 21, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...